PH-002
Modify Date: 2024-01-23 12:50:29
PH-002 structure
|
Common Name | PH-002 | ||
|---|---|---|---|---|
| CAS Number | 1311174-68-1 | Molecular Weight | 491.58 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H33N5O4 | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of PH-002PH-002 is an inhibitor of apolipoprotein (apo) E4 intramolecular domain interaction in neuronal cells that could rescue impairments of mitochondrial motility and neurite outgrowth. |
| Name | PH-002 |
|---|
| Description | PH-002 is an inhibitor of apolipoprotein (apo) E4 intramolecular domain interaction in neuronal cells that could rescue impairments of mitochondrial motility and neurite outgrowth. |
|---|---|
| Related Catalog | |
| Target |
116 nM (Apo E4 in FRET)[1]. |
| In Vitro | PH-002 is an inhibitor of apolipoprotein (apo) E4 intramolecular domain interaction in neuronal cells, with an IC50 of 116 nM in FRET[1]. |
| In Vivo | PH-002 is also shown to increase COX1 levels in primary neurons from NSE-apoE4 transgenic mouse cortex and hippocampus. After 4 days of treatment with PH-002 (200 nM), COX1 levels are increased by ~60%. PH-002 (100 nM) increases dendritic spine development in primary neurons from NSE-apoE4 transgenic mice to levels comparable with those in NSE-apoE3 primary neurons (apoE3-expressing primary neurons treated with PH-002 gave results identical to untreated primary neurons)[2]. |
| Cell Assay | Neuro-2a cells stably expressing apoE3 or apoE4 are seeded at 7500-8000 cells/well on PLlysine-coated 24-well plates containing Opti-MEM with either 0.03% DMSO (control) or DMSO plus compound PH-002 (100 nM)[1]. |
| References |
| Molecular Formula | C27H33N5O4 |
|---|---|
| Molecular Weight | 491.58 |
| Storage condition | 2-8℃ |
| RIDADR | NONH for all modes of transport |
|---|